Sarah R. Bujac
UCB Pharma (United Kingdom)(GB)
Publications by Year
Research Areas
Asthma and respiratory diseases, Lipoproteins and Cardiovascular Health, Parkinson's Disease Mechanisms and Treatments, Metabolism, Diabetes, and Cancer, Diabetes, Cardiovascular Risks, and Lipoproteins
Most-Cited Works
- → Variation in the PPARα gene is associated with altered function in vitro and plasma lipid concentrations in Type II diabetic subjects(2000)170 cited
- → Impact of ABCG2 and SLCO1B1 polymorphisms on pharmacokinetics of rosuvastatin, atorvastatin and simvastatin acid in Caucasian and Asian subjects: a class effect?(2015)148 cited
- → Rosuvastatin pharmacokinetics and pharmacogenetics in Caucasian and Asian subjects residing in the United States(2015)136 cited
- → Genetic and Environmental Determinants of Plasma Nitrogen Oxides and Risk of Ischemic Heart Disease(2001)123 cited
- → Further Evidence of Association of OPRD1 & HTR1D Polymorphisms with Susceptibility to Anorexia Nervosa(2006)89 cited
- → Contribution of Apolipoprotein C-III Gene Variants to Determination of Triglyceride Levels and Interaction With Smoking in Middle-Aged Men(2000)85 cited
- → Epidemiological and Genetic Associations of Activated Factor XII Concentration With Factor VII Activity, Fibrinopeptide A Concentration, and Risk of Coronary Heart Disease in Men(2000)84 cited
- → Analytical Validation of BRAF Mutation Testing from Circulating Free DNA Using the Amplification Refractory Mutation Testing System(2014)52 cited
- → Substitution of asparagine for aspartic acid at residue 9 (D9N) of lipoprotein lipase markedly augments risk of ischaemic heart disease in male smokers(2000)51 cited
- → Associations of IGF2 ApaI RFLP and INS VNTR class I allele size with obesity(1999)48 cited